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Decreased EEG synchronization in Alzheimer’s disease and mild cognitive impairment 
Abstract 
The hypothesis of a functional disconnection of neuro-cognitive networks in patients 
with mild cognitive impairment (MCI) and Alzheimer Dementia was investigated 
using baseline resting EEG data. EEG databases from New York (264 subjects) and 
Stockholm (155 subjects), including healthy controls and patients with varying 
degrees of cognitive decline or Alzheimer Dementia were analyzed using Global Field 
Synchronization (GFS), a novel measure of global EEG synchronization. GFS reflects 
the global amount of phase-locked activity at a given frequency by a single number; it 
is independent of the recording reference and of implicit source models. Patients 
showed decreased GFS values in Alpha, Beta and Gamma frequency bands, and 
increased GFS values in the Delta band, confirming the hypothesized disconnection 
syndrome. The results are discussed within the framework of current knowledge about 
the functional significance of the affected frequency bands. 
 
Keywords: Alzheimer’s Disease, Mild Cognitive Impairment (MCI), EEG, 
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1. Introduction 
Selective distribution of characteristic neurofibrillary pathology in Alzheimer’s 
disease (AD) follows the projection of anatomico-functional circuits of the brain [2,3]. 
During the course of the disease, the degenerative process spreads in a characteristic 
manner starting in the entorhinal region and progressing through the hippocampus and 
the limbic structures towards the neocortical association areas [2]. The disconnection is 
caused by the degeneration of the large cortical pyramidal neurons [14,16] and 
assumingly occurs at the level of cortico-cortical projections. These cortico-cortical 
projections are crucial for higher order information processing, since they permit the 
integration of multimodal information through the coherent firing of extended neural 
networks. Therefore, Morrison [27] suggested a “disconnection syndrome” as a model 
for the AD symptomatology. Since coherent firing of a sufficiently large number of 
neurons produces a detectable voltage field on the scalp, it is plausible that EEG data 
can be used to study changes in synchronization of neural circuits in AD that possibly 
occur at an early stage of the disease. 
Within this context, a novel method called Global Field Synchronization (GFS) has 
recently been introduced to measure functional synchronization in frequency-domain 
EEG data [22]. For the entire set of EEG channels and for a given frequency, a single 
GFS value is obtained representing the percentage of EEG activity that oscillated with 
a common phase. High GFS values in a given frequency indicate therefore that a large 
part of the recorded brain activity at that frequency is phase locked. The presence of 
phase locked, oscillatory brain activity has been related to short-term binding of 
neural networks and may play an important role for higher order information 
processing and cognition [13,33]. Since resting EEG usually is not assumed to originate 
from very focal sources, the amount of synchronization measured by GFS can 
 - 3 - 
Decreased EEG synchronization in Alzheimer’s disease and mild cognitive impairment 
reasonably be assumed to be mediated thru a network of cortico-cortical connections. 
Contrary to coherence, where the stability of the phase relation between two pre-
selected electrodes across analysis epochs is assessed and usually taken as indicator of 
cooperativity between the underlying regions, GFS makes no assumption about the 
spatial location of the activity. The computation of GFS assumes (in agreement with 
the existing volume conductor models of the head) that most types of measurable 
brain activity generate signals that are distributed over many electrodes on the scalp. 
If these signals show a predominant phase across all electrodes, this indicated that the 
(possibly many) local brain processes are interacting such that they appear to 
constitute a phase-locked, single and global meta-process. Compared to coherence 
that is local in space and global in time (i.e. requires selected pairs of electrodes 
recorded against a third, also pre-selected electrode, and a series of analysis epochs), 
GFS is global in space and local in time (i.e. it considers, during a single analysis 
epoch, all electrodes simultaneously and independent of the reference electrode). 
Therefore, since GFS does not require any assumptions about the location of the 
active processes, and since it can be assessed within relatively short (1-2 second) time 
periods, it may be well suited to study a hypothesized general disruption of short-
lasting functional binding between extended neural networks. Additionally, the 
frequency information provided by the measure may be used to gain further 
information about the functional significance of the assumingly disrupted processes. 
Although animal work has shown that gamma (40 Hz) activity plays an important role 
for feature binding [8] EEG research has indicated that other frequency bands are also 
crucially involved in human information processing [9]. A previous study on GFS 
comparing acutely schizophrenic patients with healthy controls has shown that 
patients had reduced GFS values in the theta band, which has been related to the 
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existing hypothesis of a disconnection of working memory processes in schizophrenia 
[22]. 
The aim of the present study was to explore and extend the hypothesis of functional 
disconnection in AD and mild cognitive impairment (MCI) as reflected in GFS. The 
study was based on two independent, large samples encompassing healthy subjects, 




2.1. Data collection in New York 
Subjects: The first group of patients was selected from consecutive, community 
residing elderly persons 50 to 89 years of age from the New York area, presenting 
with self-report of decline in cognitive functioning. Control subjects were recruited 
among healthy friends and family members of the patients. Medical, neurological, 
psychiatric and neuropsychological evaluations were conducted at the New York 
University School of Medicine (NYUSM), Aging and Dementia Research Center to 
exclude patients with conditions other than age-associated memory deficits or AD, 
which might interfere with, or confound the assessment of cognitive functioning. 
These exclusion criteria were: (a) past history of significant head trauma, seizures, 
mental retardation, or neurologic or psychiatric disorder other than AD; (b) any focal 
signs of significant neuropathology; (c) a diagnosis of multi-infarct dementia based on 
a history of cerebral infarction or transient ischemic attacks including any patients 
with a modified Hachinski score greater than or equal to 4 [34]; (d) significant history 
of alcohol or drug abuse; (e) previous history of schizophrenia, major affective 
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disorder, including any subjects with Hamilton Depression Scale (HAM-D) scores of 
16 or greater; (g) cardiac, pulmonary, vascular, metabolic, or hematologic conditions 
of sufficient severity to adversely affect cognition or functioning and (h) other 
physical impairment of sufficient severity to adversely affect cognition or functioning. 
All included subjects discontinued any psychotropic or other cognitive-acting 
medication at least 2 weeks prior to the evaluation period.  
Assessment of cognitive deterioration: All patients were assessed for the magnitude 
of cognitive decline staged from 1 to 6 on the Global Deterioration Scale (GDS) for 
age-associated cognitive decline and primary degenerative dementia [30]. Using this 
staging procedure, control subjects are assigned to GDS stage 1 and have neither 
subjective nor objective evidence for cognitive impairment, subjects at GDS stage 2 
have subjective cognitive deficits in the absence of objective impairment, subjects at 
GDS stage 3 have objective evidence of memory deficit sufficient to interfere with 
performance in demanding employment and social settings, and subjects at GDS 
stages 4 to 7 have clear evidence of cognitive deficit comparable with mild (GDS=4), 
moderate (GDS=5), and moderately severe (GDS=6) AD. Stage specific relationships 
between GDS level assignments and scores on mental status, psychometric, and 
neuro-imaging measures have been reported [30] and current data on the validity and 
reliability of this staging procedure has been reviewed [31]. 
Following these evaluative procedures, the subjects were referred for EEG recording. 
The successfully recorded population consisted of normal elderly subjects (GDS=1; 
25 subjects, mean age 67.1 years), patients with subjective complaints of cognitive 
impairment (GDS=2; 40 subjects, mean age 69.1 years), patients with mild cognitive 
impairment (GDS=3; 51 subjects, mean age 70.7 years), and patients with more 
severe deterioration associated with AD (GDS=4; 71 subjects, mean age 70.9 years; 
 - 6 - 
Decreased EEG synchronization in Alzheimer’s disease and mild cognitive impairment 
GDS=5; 56 subjects, mean age 71.7 years and GDS 6=21 subjects, mean age 74.3 
years), making a total of 264 subjects included in the analysis. Diagnosis of probable 
AD was based on DSM-IIIR [1]. There were no significant differences in age between 
any group of patients or controls. All subjects or legal representatives gave their 
written informed consent before participating in the study (as approved by NYUSM 
institutional review board). 
EEG recording: Twenty minutes of eyes closed awake resting digital EEG data were 
collected from the 19 electrode sites of the International 10/20 System, referred to 
linked earlobes, while the subjects were seated comfortably in a light and sound 
attenuated room. The EEG was monitored throughout the recording for drowsiness 
and the patient was alerted if observed. Amplifiers had a bandpass from 0.5 to 70Hz 
(-3dB point). A differential eye channel placed on the outer left canthus was used to 
detect eye movements. All electrode impedances were below 5 kOhms, the sampling 
rate was 200 Hz. From the digital EEG, artifact-free epochs with a minimal duration 
of 2.5 seconds were selected offline by an automatic artifact rejection algorithm 
(based on channel-wise absolute amplitude thresholds) augmented by visual 
inspection by electrophysiologically expert editors. These editors eliminated any 
EOG, EMG, ECG or lateral eye-movement eluded by the automatic algorithm. The 
artifact exclusion procedure has been described and validated elsewhere [21]. The 
minimal total amount of available artifact free data was 1 minute per subject. 
2.2. Data collection in Stockholm 
Subjects: The second group of subjects was recruited among patients that were 
consecutively referred between 1995 and 1999 to the in- or out-patient Department of 
the Geriatric Clinic, Huddinge University Hospital, Stockholm, Sweden, for memory 
problems and investigation for suspected dementia. Sources of referral included 
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general practitioners, neurologists, specialists of occupational medicine, or individuals 
seeking help directly because of self-experienced memory problems. Control subjects 
were recruited among the healthy family members of the patients and among healthy 
subjects recruited for a Driving and Aging project. All subjects underwent a careful 
physical, psychiatric and neurological examination as well as detailed 
neuropsychological assessment. Exclusion criteria were evidence of previous head 
trauma, previous infectious disease of the central nervous system, psychiatric illness 
or medication with psychotropic drugs and severe somatic diseases that could 
influence cognitive performance of the subjects. In addition, all patients performed 
MRI investigations to rule out eventual other causes of dementia like brain tumors, 
normotensive hydrocephalus, as well as SPECT investigations to support clinical 
diagnosis of AD by a typical finding of a reduced temporo-parietal cerebral blood 
flow [5,35]. 
EEG recordings in AD patients were performed before treatment with any 
psychoactive or cognition enhancing drug had been initiated. The study was approved 
by the local ethical committee. 
Assessment of cognitive deterioration: The global level of cognitive functioning of 
all subjects was assessed using the Mini Mental State Examination (MMSE)[10] and 
the Full Scale IQ scores based on the four Wechsler subtests (FSIQ) [36]. The 
diagnosis of dementia was based on DSM-III-R criteria [1], and NINCDS-ADRDA 
criteria [26] served to establish a diagnosis of probable AD. The subjects were divided 
into the following 5 groups: a) healthy subjects with no signs of memory impairment 
(Controls; n=21, mean age 63.4 years), b) subjects who reported memory loss, but 
scored within 1 standard deviation (SD) from the age norm on the neuropsychological 
tests performed (Subjective memory impairment; n=30, mean age 58.3 years), c) 
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subjects who scored between 1 and 2 SD below the age norm on the 
neuropsychological tests, but did not fulfill diagnostic criteria for dementia (Objective 
memory impairment; n=41, mean age 61.0 years), d) patients meeting the criteria for 
dementia (DSM-III-R) and AD (NINCDS-ADRDA) with MMSE score of at least 20 
(Mild AD; n=45, mean age 62.0 years), and e) patients meeting the criteria for 
dementia (DSM-III-R) and Alzheimer’s disease (NINCDS-ADRDA) with MMSE 
score between 15 and 20 (Moderate AD; n=18, mean age 63.0). The successive 
groups were considered equivalent to the New York groups GDS 1 through 5. The 
total number of subjects was therefore 155 subjects, in an ANOVA, there was no 
significant effect of diagnostic group on age. Since the data collection in Stockholm 
had an emphasis on early detection these subjects in Stockholm were in the average 
9.3 years younger than the subjects from New York. 
EEG recording: Eyes closed resting EEG was recorded from 19 scalp electrodes 
applied according to the standard international 10/20 system. The EEG was recorded 
against linked ear lobes, band pass filtered between 1 and 30 Hz and digitized at 128 
Hz. Artifact free 2 second epochs were selected by visual inspection, and at least 20 
seconds of artifact free EEG data were available for each subject. This differed form 
the data collected in New York, but since later, GFS was computed separately in each 
epoch and averaged across epochs, and since it has been shown that 20 sec of EEG are 
sufficient to reduce adequately the EEG variability [11], this was not considered to be a 
problem for the reproducibility of results between the two centers.  
2.4. Group labeling 
For issues of clarity, a common labeling of the various degrees of cognitive decline 
and AD was used for both study centers: Controls (GDS 1 in New York, Controls in 
Stockholm), subjective memory impairment (GDS 2 in New York, subjective memory 
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impairment in Stockholm), mild cognitive impairment (GDS 3 in New York, 
objective memory impairment in Stockholm), mild AD (GDS 4 in New York, mild 
AD in Stockholm), moderate AD (GDS 5 in New York, moderate AD in Stockholm), 
and moderately severe AD (GDS 6 in New York, not available in Stockholm). 
2.5. GFS Computation 
The computation of GFS has been described in detail in Koenig et al. [22]; and is 
reviewed here: At a given frequency, GFS measures the relative presence or absence 
of a common phase over all electrodes. For its computation, each EEG epoch is 
frequency transformed using the Fast Fourier Transformation (FFT). For each 
frequency, the real and complex parts of the signal of one electrode constitute a two-
dimensional vector; where origin of the vector represents the reference electrode, the 
length of the vector indicates the power of the signal and the direction of the vector 
represents the phase. If the signals from all electrodes would be in perfect phase or 
counter-phase, the vectors representing the signals would all point in the same or 
opposite direction and the endpoints of the vectors would thus lie on a straight line. If 
there would be no common phase, the vectors would point into different directions, 
and the endpoints of the vectors would be scattered. In order to determine how much 
the endpoints of the vectors approximate a straight line, they are entered into a two-
dimensional principal component (PC) analysis: The more the eigenvalue of the first 
PC exceeds the eigenvalue of the second PC, the more the endpoints approximate a 
straight line. If the first and the second PC are nearly equal, the vectors’ end points are 
scattered. The GFS value is thus determined as that percentage of the total power that 
can maximally be explained by a single phase [22]. GFS ranges from 0 to 1, high GFS 
values indicate the presence of a single, predominant phase over all electrodes, 
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whereas low GFS indicate the absence of such a common phase. GFS is independent 
of the total power of the data and of the recording reference. 
In the present data, GFS values were computed in each 2 sec EEG epoch and 
averaged separately for each frequency band (Delta: 1-4 Hz, Theta: 4.5-7.5Hz, Alpha: 
8-12Hz, Beta 12.5-30Hz and only for the dataset from New York Gamma: 35-45 Hz) 
within each subject. The software used for computing GFS is freely available at 
www.puk.unibe.ch/tk2/tk.htm (follow the ‘Software’ link). 
2.6. Statistical analysis 
Statistical analysis was based on single factor analyses of variance (ANOVAs) of 
GFS in each frequency band, using the degree of impairment as an independent 
variable. The datasets from the two recruitment sites were analyzed separately. In 
those frequency bands where significant group effects were found, the differences 
between groups were assessed using Fisher’s test for post hoc comparisons. The level 
of significance was set at 5%. 
 
3. Results 
The GFS means and SD for the different patient groups, frequency bands and 
recruitment sites are shown in Fig. 1.  
 
Figure 1 about here 
 
The ANOVAs on GFS as functions of the degree of impairment showed significant 
effects in the Delta band only in the data set from New York (F(5,258) = 2.52, 
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p = 0.030). In the Theta band, no effects were found in both recruitment sites. The 
Alpha band showed highly significant effect in both recruitment sites (Stockholm: 
F(4,148) = 7.81, p<0.0001; New York: F(5,258) = 8.83, p < 0.0001). In the Beta 
band, there was a significant effect in the dataset from New York (F(5,258) = 5.70, 
p < 0.0001) and a similar effect (although not reaching significance) in Stockholm 
(F(4,148) = 2.194, p = 0.072). No significant effects were found in the Gamma band 
(only computed in the New York data). The results of the post-hoc comparisons are 
summarized in Table 1.  
Although in the Gamma band, the ANOVA over all subject groups from New York 
was not significant, Gamma band GFS values were lower in all patient groups patients 
compared to controls (Fig. 1). Therefore, a single, two-tailed t-test was computed 
comparing Gamma band GFS between control subjects and with any degree of 
impairment. (This is equivalent to a single factor ANOVA comparing controls and 
patients). This t-test was significant (t(262) = 2.33, p = 0.02). 
 
Table 1 about here 
Table 2 about here 
 
4. Discussion  
The analysis of GFS in elderly patients with various degrees of cognitive decline 
indicated a generally reduced amount of synchronized brain electric activity compared 
with normal controls. This finding is consistent with earlier EEG studies using 
coherence between pairs of electrodes [20,24,25]. However, the assumptions underlying 
the present results and the results obtained with coherence differ considerably: The 
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coherence studies contain an implicit local source model by assuming that the signal 
recorded at one electrode represents only the activity underneath that electrode and 
not activity from other sources. Due to volume conduction and tangentially oriented 
generators, this is generally not the case. On the other hand, GFS measures 
synchronization on a spatially global level, where the neural activity oscillating with a 
common phase is considered as a single process, no matter where these neurons were 
distributed. Therefore, the computation of GFS implies no source-localization model. 
Another major difference is the temporal extend of the measures: Coherence measures 
the stability of phase relations over many epochs and therefore requires the signals to 
be stationary over these epochs. GFS assumes the signals to be stationary only within 
a single, short EEG epoch. Whereas coherence is thus local in space, but global in 
time, GFS is global in space and local in time. 
The relation between GFS and degree of cognitive decline was similar for both 
recruitment sites, and dependent on frequency bands. The most pronounced effects 
were found in the alpha band. There was an almost continuous decrease of GFS with 
increasing cognitive impairments in the New York group, and in the Stockholm data 
set, the patients with a diagnosis of probable AD had lower GFS values compared to 
all other groups. This finding is interesting for several reasons: First, in normal 
controls, the GFS values were highest in the alpha band, and it may therefore be that 
neurodegenerative processes affect neural synchronization first in this frequency 
band. Second, alpha activity in normal subjects originates predominantly in posterior 
regions, where other imaging modalities have reported the first functional changes in 
AD [15,29]. Furthermore, in AD patients, the location of alpha sources correlated 
positively with brain glucose metabolism as assessed using positron emission 
tomography [6]. These findings suggest that a usually well-organized alpha activity 
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disintegrates in time and changes in space with progressive deterioration in AD 
patients, independent of the other bands. Furthermore, these findings suggest that 
theta power abnormalities reported in QEEG studies [28] as a correlate of cognitive 
deterioration may reflect a process that is independent from the reported GFS 
deviations. 
The results found in the beta band were similar to those in the alpha band showing 
decreased synchronization in more impaired subjects. The beta band has classically 
been related to excitatory activity and cognitive processes that deteriorate during AD. 
Furthermore, beta spectral power has also been shown to decrease in AD [17].  
In the patient groups, GFS values were also found to be decreased in the gamma band. 
This effect might either be a continuation of the effects seen in the beta band or it may 
relate to the 40 Hz activity described in animal studies which is involved in the 
establishment of synchrony among widely distributed neurons [23]. However, since 
GFS values in the Gamma band showed a much larger inter-individual variance 
compared to the other frequency bands, and since it did not differentiate between the 
patient groups, its relevance for EEG synchronization in AD remains open. 
In the delta band, GFS was selectively increased in the most impaired patients 
(patients with GDS = 6; these patients were only present in the data-set from New 
York). This apparently contradictory finding could possibly be explained by the 
progressive cortical cholinergic deafferentation observed in AD [12]. In animal lesion 
studies, increased delta activity has been reported after destruction of the Nucleus 
Basalis [4], the main production site of acetylcholin[32]. In humans, it has also been 
demonstrated that delta abnormalities occur only in the later stages of deterioration. 
Furthermore, treatment response after long-term therapy with acetylcholinesterase 
inhibitors in AD patients showed reduction in delta and theta activity [18].  
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The present results are therefore considered to be compatible with the hypothesis of a 
neurofunctional disconnection in AD. However, although the results from the two 
datasets gave converging support for this hypothesis, there are also important 
differences between the datasets that need to be mentioned. In the dataset from 
Stockholm, there were nearly no differences in alpha GFS between healthy controls 
and subjects with subjective memory impairments or mild cognitive impairment. In 
the dataset from New York however, alpha and beta band GFS decreased nearly 
continuously with increasing impairment. There were nearly significant GFS 
differences already between controls and patients with mild cognitive impairment in 
the alpha band, and even significant differences between controls and patients with 
subjective memory impairment in the beta band. It is thus not clear whether the GFS 
differences described here can be used as state marker of cognitive decline (as the 
data from New York suggests) or as trait marker of AD (what the data from 
Stockholm suggests), and what role the different assessment systems played in this 
context.  
In general, the method seems to be promising for further EEG research, since its 
computation relies on few assumptions that allow a comprehensive interpretation and 
since its global characteristics simplify statistics. Furthermore, it would be of interest 
to investigate whether previously reported differences in EEG coherence between AD 
and other typed of dementia (i.e vascular dementia [24]) are similarly reflected in GFS. 
Interestingly, differential decrease in GFS has been demonstrated in our recent study 
where patients with frontal lobe dementia (FLD) were compared to AD patients and 
healthy individuals [19], where FLD patients had significantly lower GFS in all 
frequency bands when compared to both AD patients and healthy elderly controls. 
Future correlative studies with functional and structural neuroimaging methods and 
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indices of neuropsychological performance in patients with dementia should thus add 
to the understanding of the functional and behavioral relevance of GFS. 
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Tables 
Table 1: Significant differences* in the frequency bands between the groups of 
healthy subjects and patients in different stages of the disease, New York data. 
Group Delta  Theta  Alpha   Beta Gamma 
C vs S n.s.  -   n.s.  * ↓  - 
C vs O n.s.  -  (* ↓)  * ↓  - 
C vs Mild AD n.s.  -  * ↓  * ↓  - 
C vs Mod AD n.s.  -  * ↓  * ↓  - 
C vs Mod sev AD * ↑  -  * ↓  * ↓  - 
S vs O n.s.  -  n.s.  n.s.  - 
S vs Mild AD n.s.  -  * ↓  (*↓)  - 
S vs Mod AD n.s.  -  * ↓  * ↓  - 
S vs Mod sev AD * ↑  -  * ↓  * ↓  - 
O vs Mild AD n.s.  -  (*↓)  * ↓  - 
O vs Mod AD n.s.  -  * ↓  * ↓  - 
O vs M sev AD * ↑  -  * ↓  * ↓  - 
Mild AD vs Mod AD n.s.  -  (*↓)  n.s.  - 
Mild AD vs M sev AD * ↑  -  * ↓  n.s.  - 
Mod AD vs M sev AD * ↑  -  n.s.  n.s.  - 
* p<0.05; (*) 0.05 < p < 0.1; Fisher’s test for post-hoc comparisons. C – controls, S – 
subjective memory impairment, O – objective cognitive impairment, Mild AD – mild 
Alzheimer’s disease, Mod AD – moderate Alzheimer’s disease, M sev AD – 
moderately severe AD. The dash indicates the ANOVA was not significant and no 
post-hoc tests were computed, arrows indicate the direction of the change.
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Table 2: Significant differences* in the frequency bands between the groups of 
healthy subjects and patients in different stages of the disease, Stockholm data. 
Group    Delta  Theta  Alpha   Beta  
C vs S    -  -  n.s.  n.s. 
C vs O    -  -  n.s.  n.s. 
C vs Mild AD   -  -  * ↓  * ↓ 
C vs Mod AD   -  -  * ↓  * ↓ 
S vs O    -  -  n.s.  n.s. 
S vs Mild AD   -  -  * ↓  (*↓) 
S vs Mod AD   -  -  * ↓  * ↓ 
O vs Mild AD   -  -  * ↓  n.s. 
O vs Mod AD   -  -  * ↓  n.s. 
Mild AD vs Mod AD  -  -  n.s.  n.s. 
* p<0.05; (*) 0.05 < p < 0.1; Fisher’s test for post-hoc comparisons. 
C – controls, S – subjective memory impairment, O – objective cognitive impairment,  
Mild AD – mild Alzheimer’s disease, mod AD – moderate Alzheimer’s disease. The 
dash indicates the ANOVA was not significant and no post-hoc tests were computed, 
arrows indicate the direction of the change. 
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Figure legend 
Fig. 1: Means and standard deviations of the obtained GFS values (vertical axis) for 
the different frequency bands (horizontal axis). Increasing darkness of the bars 
indicate increased impairment. Upper graph: data from New York, lower graph: data 
from Stockholm. * indicates frequency bands were the ANOVA was significant, (*) 
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